NCT01853787 - Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Formoterol Fumarate

Formoterol Fumarate, one inhalation of 12 mcg via MDI (Metered Dose Inhaler) Modulite will be taken in double blind randomized way immediately after T0 evaluation.

DRUG

Salmeterol

Salmeterol 50 mcg via MDI (Metered Dose Inhaler), one inhalation only, immediately after T0 evaluation

Trial Locations (2)

20138

: Pneumologia Riabilitativa-Fondazione Maugeri-Istituto Scientifico di Milano- IRCCS, Milan

44121

Clinica di Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Mediche, Università di Ferrara, Ferrara

All Listed Sponsors

collaborator

Fondazione Salvatore Maugeri

OTHER

collaborator

Università degli Studi di Ferrara

OTHER

lead

University of Milan

OTHER